A week after his synthetic genome paper appeared in Nature, J. Craig Venter and others appeared before the US House Committee on Energy and Commerce to discuss the burgeoning technology. In particular, lawmakers were interested in what synthetic biology is, its future, its regulation, and whether it is dangerous.
Short Reads
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.